Overall Perfomance for "OTC Stock Review"
The following three charts can be used by potential investors to gauge the performance of "OTC Stock Review":
14 out of 35 campaigns closed down on first day
16 out of 35 campaigns closed up on first day
5 out of 35 campaigns had no net effect
BYND Promotional Newsletter
The following is a newsletter released by "OTC Stock Review" promoting Beyond Meat, Inc.
OTC Stock Review Award Winning Small Cap Stock Picks Since 2004
BYND Cannasoft Enterprises
BYND Cannasoft Enterprises NASDAQ BCAN CSE BYND is definitely in play. After news of a $28 million acquisition last night, the stock traded from $4.17 to over $20.00 in after hours trading. We believe there will be more interesting news on BCAN, but don't chase the stock. Let it settle and look for an entry point. We will be sending out additional updates.
BYND Cannasoft Enterprises Inc. Signs Agreement for the Acquisition of Israeli-Based Zigi Carmel Initiatives Investments Ltd. In a Share Swap Agreement Valued at US $28 Million
ZC owns the patent pending intellectual property for a CBD-based therapeutic device combined with software designed to treat phenomena related to women's health issues by regulating the flow of low-concentration CBD oils into the soft tissues of the female reproductive system
VANCOUVER, British Columbia, Sept. 18, 2022 GLOBE NEWSWIRE -- BYND Cannasoft Enterprises Inc. NASDAQ BCAN CSE BYND BYND or the Company announced today that it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives Investments Ltd. ZC which holds the patent pending intellectual property for a therapeutic device the EZ-G device that uses low concentrations of CBD oils, such as hemp seed oil and other natural oils, to treat certain women's health issues. Under the terms of the share purchase agreement, the Company will issue to ZCs owner 7,920,000 common shares at a deemed price per share of $4.735 subject to closing the transaction by October 10, 2022 and pay US $100,000 to cover his legal expenses. The closing of the transaction is subject to certain customary conditions. BYND expects the transaction to close this month.
The EZ-G device is a unique, patent-pending device that, combined with proprietary software provisional application, regulates the flow of low-concentration CBD oils into the soft tissues of the female reproductive system. According to research conducted across the globe, treatment with low-concentration CBD oils can relieve candida, dryness, scars, and many other female health issues.
NASDAQ Symbol BCAN
CSE Symbol BYND
Friday's Close $4.17
Current Price After HoursPremarket $14.05
Market Cap $123 million
52 Week Trading Range
52-Week Low $4.04
52-Week High $13.10
2264 East 11th Avenue
Vancouver, BC V5N 1Z6 Canada
Telephone 604 8336820
OTC Stock Review is not registered as an Investment Advisor or a BrokerDealer. The information in this newsletter is not an offer to buy or sell securities of the companies profiled. Information is for informative purposes, not intended as advice for investment and is subject to change without notice. OTC Stock Review is compensated eight thousand five hundred dollars per month to perform investor relations services for bcanbynd. Officers and directors of OTC Stock Review hold a long equity position in ebcanbynd and may from time to time trade in these securities for their own accounts. Information on each company is from public releases and can not be guaranteed by OTC Stock Review. Companies profiled herein may carry a high investment risk readers should carefully review profiled companies thoroughly with their investment advisor, stockbroker, or other such professional. OTC Stock Review is not liable for any investment decisions by its readers or their advisors. Any analysis contained herein does not purport to be a complete analysis of the profiled Companies and reflects the opinion of the author. Readers should obtain copies of the profiled Companys periodic reports filed with United States Securities and Exchange Commission, generally available at or .
If you no longer wish to receive these emails, please reply to this message with Unsubscribe in the subject line or simply click on the following link
OTC Stock Review
3455 Peachtree Rd. N.E.
Atlanta, Georgia 30328
the marketing policy.
Last 2 Stock Promotions By "OTC Stock Review"
|HENC||Hero Technologies Inc.||September 13, 2022||0.045||32%|
|SLDX||STELLA DIAGNOSTICS INC.||July 21, 2022||0.440||120%|